COG-ALTE22C1: Chronic Health Conditions in Down Syndrome-Associated Acute Leukemia: The Down Syndrome Phenotyping Acute Leukemia Study in Survivors (DS-PALS Survivors)

Objective

This study attempts to learn more about the health of persons with Down syndrome after treatment for acute leukemia. Children with Down syndrome are at increased risk for side effects during treatment for acute leukemia, but it is unclear of their risk for long-term effects of cancer treatment. By learning more about the factors that may contribute to chronic health conditions and long-term effects after treatment for leukemia in persons with Down syndrome, clinical practice guidelines for survivorship care can be developed to help improve their quality-of-life.

National Clinical Trial (NCT) Number: 05702645

National Library of Medicine clinicaltrials.gov Website Address: https://clinicaltrials.gov/study/NCT05702645

Location: Essentia Health Cancer Centers

Research Study Categories

• Pediatric Oncology Studies

Specialties

• Cancer Control/Prevention
• Leukemia

Contact

Cancer Clinical Trials at 218-786-3308 or 844-681-7944, [email protected]